ENvue Medical Statistics
Total Valuation
ENvue Medical has a market cap or net worth of 951,429. The enterprise value is 1.18 million.
| Market Cap | 951,429 |
| Enterprise Value | 1.18M |
Important Dates
The next estimated earnings date is Friday, November 13, 2026.
| Earnings Date | Nov 13, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
ENvue Medical has 923,717 shares outstanding. The number of shares has increased by 1,812.95% in one year.
| Current Share Class | 923,717 |
| Shares Outstanding | 923,717 |
| Shares Change (YoY) | +1,812.95% |
| Shares Change (QoQ) | +87.20% |
| Owned by Insiders (%) | 0.00% |
| Owned by Institutions (%) | 2.66% |
| Float | 923,713 |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.49 |
| PB Ratio | 0.03 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 0.61 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.66, with a Debt / Equity ratio of 0.04.
| Current Ratio | 0.66 |
| Quick Ratio | 0.22 |
| Debt / Equity | 0.04 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.11 |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -59.14% and return on invested capital (ROIC) is -25.26%.
| Return on Equity (ROE) | -59.14% |
| Return on Assets (ROA) | -20.99% |
| Return on Invested Capital (ROIC) | -25.26% |
| Return on Capital Employed (ROCE) | -48.53% |
| Weighted Average Cost of Capital (WACC) | 4.97% |
| Revenue Per Employee | 148,154 |
| Profits Per Employee | -3.78M |
| Employee Count | 14 |
| Asset Turnover | 0.04 |
| Inventory Turnover | 1.01 |
Taxes
| Income Tax | -353,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -98.68% in the last 52 weeks. The beta is 1.37, so ENvue Medical's price volatility has been higher than the market average.
| Beta (5Y) | 1.37 |
| 52-Week Price Change | -98.68% |
| 50-Day Moving Average | 4.57 |
| 200-Day Moving Average | 18.49 |
| Relative Strength Index (RSI) | 17.48 |
| Average Volume (20 Days) | 111,615 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 0.08 |
Income Statement
In the last 12 months, ENvue Medical had revenue of 1.93 million and -49.19 million in losses. Loss per share was -206.88.
| Revenue | 1.93M |
| Gross Profit | -502,000 |
| Operating Income | -15.09M |
| Pretax Income | -21.42M |
| Net Income | -49.19M |
| EBITDA | -14.14M |
| EBIT | -15.09M |
| Loss Per Share | -206.88 |
Balance Sheet
The company has 1.08 million in cash and 1.31 million in debt, with a net cash position of -226,000 or -0.24 per share.
| Cash & Cash Equivalents | 1.08M |
| Total Debt | 1.31M |
| Net Cash | -226,000 |
| Net Cash Per Share | -0.24 |
| Equity (Book Value) | 30.76M |
| Book Value Per Share | 45.04 |
| Working Capital | -2.49M |
Cash Flow
In the last 12 months, operating cash flow was -11.65 million and capital expenditures -95,000, giving a free cash flow of -11.74 million.
| Operating Cash Flow | -11.65M |
| Capital Expenditures | -95,000 |
| Depreciation & Amortization | 951,000 |
| Net Borrowing | -1.00M |
| Free Cash Flow | -11.74M |
| FCF Per Share | -12.71 |
Margins
| Gross Margin | -26.06% |
| Operating Margin | -783.59% |
| Pretax Margin | -1,111.94% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
ENvue Medical does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -1,812.95% |
| Shareholder Yield | -1,812.95% |
| Earnings Yield | -5,169.91% |
| FCF Yield | -1,234.35% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on September 1, 2026. It was a reverse split with a ratio of 0.0833333.
| Last Split Date | Sep 1, 2026 |
| Split Type | Reverse |
| Split Ratio | 0.0833333 |
Scores
ENvue Medical has an Altman Z-Score of -5.55 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -5.55 |
| Piotroski F-Score | 1 |